Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 May;1(3):271-6.
doi: 10.1007/s11910-001-0030-x.

Infection and the etiology and pathogenesis of multiple sclerosis

Affiliations
Review

Infection and the etiology and pathogenesis of multiple sclerosis

I Steiner et al. Curr Neurol Neurosci Rep. 2001 May.

Abstract

Multiple sclerosis (MS) currently defies clinical and scientific definitions, and carries a prognosis that remains practically unchanged despite many years of intensive research. Although the prevailing dogma is that MS is an immune-mediated condition, it fulfills none of the criteria of an autoimmune disease. On the other hand, there is enough significant data to suggest that infectious agents(s) could be involved in either direct damage to the white matter or induce inflammatory responses that secondarily affect the brain. Our goal here is to review the data supporting the possibility that infection has a critical role in the disease, examine the list of potential candidates that have been suggested, and outline an approach regarding the potential role of infectious agents in the etiology and pathogenesis of MS.

PubMed Disclaimer

References

    1. Steiner I, Wirguin I. Multiple sclerosis-in need of critical reappraisal. Med Hypoth. 2000;51:99–106. doi: 10.1054/mehy.1998.0835. - DOI - PubMed
    1. Schumacher GA, Beebe G, Kubler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sci. 1965;122:522–568. - PubMed
    1. Marie P. Sclerose en plaques et maladies infectieuses. Prog Med. 1884;12:287–289.
    1. Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707–717. doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. - DOI - PubMed
    1. Ebers GC, Sadovnick AD. Epidemiology. In: Paty DW, Ebers GC, editors. Multiple Sclerosis. Philadelphia: FA Davis; 1998. pp. 5–28.

MeSH terms